tiprankstipranks
Sarepta Therapeutics (SRPT)
NASDAQ:SRPT
Holding SRPT?
Track your performance easily

Sarepta Therapeutics (SRPT) Income Statement

3,033 Followers

Sarepta Therapeutics Income Statement

Last quarter (Q3 2024), Sarepta Therapeutics's total revenue was $467.17M, an increase of 40.79% from the same quarter last year. In Q3, Sarepta Therapeutics's net income was $33.61M. See Sarepta Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 1.64B$ 1.24B$ 933.01M$ 701.89M$ 540.10M$ 380.83M
Cost of Revenue
$ 94.73M$ 150.34M$ -139.99M$ 97.05M$ -63.38M$ -66.59M
Gross Profit
$ 1.60B$ 1.09B$ 793.02M$ 604.84M$ 476.72M$ 447.42M
Operating Expense
$ 1.33B$ 1.36B$ 1.33B$ 1.05B$ 1.04B$ 1.02B
Operating Income
$ 81.03M$ -267.82M$ -536.20M$ -459.71M$ -564.16M$ -705.56M
Net Non Operating Interest Income Expense
$ -66.53M$ -63.96M$ -36.76M$ -63.17M$ -56.98M$ -23.43M
Other Income Expense
$ -661.21M$ -316.23M$ 64.52M$ -130.25M$ -95.33M$ 8.32M
Pretax Income
$ 129.40M$ -520.10M$ -689.96M$ -418.95M$ -553.07M$ -713.88M
Tax Provision
$ 7.52M$ 15.88M$ 13.53M$ -168.00K$ 1.06M$ 1.20M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 121.84M$ -535.98M$ -703.49M$ -418.78M$ -554.13M$ -581.85M
Basic EPS
$ 1.59$ -5.80$ -8.03$ -5.15$ -7.11$ -9.71
Diluted EPS
$ 1.57$ -5.80$ -8.03$ -5.15$ -7.11$ -9.71
Basic Average Shares
$ 387.77M$ 92.40M$ 87.56M$ 81.26M$ 77.96M$ 73.61M
Diluted Average Shares
$ 402.48M$ 92.40M$ 87.56M$ 81.26M$ 77.96M$ 73.61M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 1.37B$ 1.51B$ 1.19B$ 947.49M$ 977.54M$ 953.17M
Net Income From Continuing And Discontinued Operation
$ 121.84M$ -535.98M$ -703.49M$ -418.78M$ -554.13M$ -715.08M
Normalized Income
$ 44.24M---$ -436.32M$ -563.97M
Interest Expense
------
EBIT
$ 149.19M$ -498.09M$ -636.72M$ -355.42M$ -493.12M$ -683.21M
EBITDA
$ 187.83M$ -453.69M$ -594.85M$ -317.41M$ -466.21M$ -667.16M
Currency in USD

Sarepta Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis